216 related articles for article (PubMed ID: 24037342)
1. Dominant effects of Δ40p53 on p53 function and melanoma cell fate.
Takahashi R; Markovic SN; Scrable HJ
J Invest Dermatol; 2014 Mar; 134(3):791-800. PubMed ID: 24037342
[TBL] [Abstract][Full Text] [Related]
2. Δ40p53 isoform up-regulates netrin-1/UNC5B expression and potentiates netrin-1 pro-oncogenic activity.
Sun Y; Manceau A; Frydman L; Cappuccio L; Neves D; Basso V; Wang H; Fombonne J; Maisse C; Mehlen P; Paradisi A
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34470826
[TBL] [Abstract][Full Text] [Related]
3. Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells.
Melo Dos Santos N; de Oliveira GAP; Ramos Rocha M; Pedrote MM; Diniz da Silva Ferretti G; Pereira Rangel L; Morgado-Diaz JA; Silva JL; Rodrigues Pereira Gimba E
J Biol Chem; 2019 Jun; 294(24):9430-9439. PubMed ID: 31028175
[TBL] [Abstract][Full Text] [Related]
4. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
5. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
7. A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.
Carson C; Omolo B; Chu H; Zhou Y; Sambade MJ; Peters EC; Tompkins P; Simpson DA; Thomas NE; Fan C; Sarasin A; Dessen P; Shields JM; Ibrahim JG; Kaufmann WK
Pigment Cell Melanoma Res; 2012 Jul; 25(4):514-26. PubMed ID: 22540896
[TBL] [Abstract][Full Text] [Related]
8. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
9. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells].
Wang BS; Zhao HW; Qiao LX; Shan JQ; Hou QS; Chen DX; Guo HL
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):332-338. PubMed ID: 28535648
[No Abstract] [Full Text] [Related]
11. Reversible induction of translational isoforms of p53 in glucose deprivation.
Khan D; Katoch A; Das A; Sharathchandra A; Lal R; Roy P; Das S; Chattopadhyay S; Das S
Cell Death Differ; 2015 Jul; 22(7):1203-18. PubMed ID: 25721046
[TBL] [Abstract][Full Text] [Related]
12. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
13. The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
Levandowski CB; Jones T; Gruca M; Ramamoorthy S; Dowell RD; Taatjes DJ
PLoS Biol; 2021 Aug; 19(8):e3001364. PubMed ID: 34351910
[TBL] [Abstract][Full Text] [Related]
14. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
[TBL] [Abstract][Full Text] [Related]
15. DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death.
Hill R; Madureira PA; Waisman DM; Lee PW
Oncotarget; 2011 Dec; 2(12):1094-108. PubMed ID: 22190353
[TBL] [Abstract][Full Text] [Related]
16. p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.
Steffens Reinhardt L; Groen K; Zhang X; Morten BC; Wawruszak A; Avery-Kiejda KA
Cell Death Dis; 2023 Aug; 14(8):509. PubMed ID: 37553320
[TBL] [Abstract][Full Text] [Related]
17. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway.
Li Q; Li J; Wen T; Zeng W; Peng C; Yan S; Tan J; Yang K; Liu S; Guo A; Zhang C; Su J; Jiang M; Liu Z; Zhou H; Chen X
Oncotarget; 2014 Aug; 5(15):6387-403. PubMed ID: 25051367
[TBL] [Abstract][Full Text] [Related]
19. The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
Hofstetter G; Berger A; Berger R; Zorić A; Braicu EI; Reimer D; Fiegl H; Marth C; Zeimet AG; Ulmer H; Moll U; Zeillinger R; Concin N
Int J Gynecol Cancer; 2012 Mar; 22(3):372-9. PubMed ID: 22246403
[TBL] [Abstract][Full Text] [Related]
20. Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells.
Lin SY; Lai WW; Chou CC; Kuo HM; Li TM; Chung JG; Yang JH
Melanoma Res; 2006 Dec; 16(6):509-19. PubMed ID: 17119452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]